Effect of Pelvic Floor Muscle Rehabilitation in Preventing Recurrent Vulvovaginal Candidiasis and Recurrent Bacterial Vaginosis
Journal of Gynecology and Obstetrics
Volume 6, Issue 4, July 2018, Pages: 94-97
Received: Jul. 10, 2018;
Accepted: Jul. 24, 2018;
Published: Sep. 13, 2018
Views 913 Downloads 80
Cheng Fang, Maternity and Child Care Hospital of Huaian in Jiangsu Province, Huaian, China
Yang Yun-Jie, Maternity and Child Care Hospital of Huaian in Jiangsu Province, Huaian, China
Shi Wen-jing, Maternity and Child Care Hospital of Huaian in Jiangsu Province, Huaian, China
Wang Xue-Ying, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China
Ma Le, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China
Follow on us
Objective To investigate the effect of pelvic floor muscle rehabilitation on recurrent vulvovaginal candidiasis (RVVC) and recurrent bacterial vaginosis (RBV). Methods Between January 2014 and July 2015, 121 cases of RVVC and RBV were selected, and the patients were randomly divided into control group and experimental group. For the control group of RVVC: miconazole suppository and vaginal delivery were utilized in every patient, 1 piece per night, the period of treatment was 7 to 14 days; oral intake of fluconazole was used again after 72 hours. Clotrimazole suppository or fluconazole was still chosen for the maintenance treatment: (1) 1 piece per week and lasted 6 months for every case; (2) 400 mg of itraconazole was used, 1 time every month or 100 mg was used once a week, the period of treatment lasted for 6 months. RBV: oralintake of metronidazole or clindamycin was chosen. One piece of metronidazole suppository by vaginal utilization was still needed per night, or 2% clindamycin ointment was used by inunction for 7 days. Experimental group: pelvic floor muscle rehabilitation. Results Before rehabilitation treatment, there were 4 cases with level 4 or 5 of type I muscle strength and 8 cases level 4 or 5 of type II muscle strength. After the treatment, there were 59 cases with level 4 or 5 of type I muscle, and 60 cases with level 4 or 5 of type II muscle (P＜0.001). There were no statistical differences on the treatment of anterior vaginal wall prolapse. Before the treatment, the number of anterior vaginal wall prolapse was 53 cases, the number was 49 cases after treatment (P=0.328). Before treatment, the number of posterior vaginal wall prolapse was 25 cases, the number was11 cases after treatment (P=0.005). The number of Uterine prolapse was 14 cases, the number was 2 cases after treatment (P=0.002). Compared with the group with drug treatment, the rate of relapse in vaginitis was decreased significantly after pelvic floor rehabilitation within 1 year, 61 patients with vaginitis, there were only 2 cases of recurrences were observed after treatment (P＜0.05). Conclusion Pelvic floor rehabilitation treatment could improve the pelvic floor function significantly, and also get significant recovery of sagging and prolapse in vagina which was injured by pregnancy and childbirth. Compared with the drug treatment group, the rate of relapse in RVVC and RBV was decreased significantly after pelvic floor muscle rehabilitation.
Pelvic Organ Prolapse, Pelvic Floor Muscle Rehabilitation, Recurrent Vulvovaginal Candidiasis, Recurrent Bacterial Vaginosis
To cite this article
Effect of Pelvic Floor Muscle Rehabilitation in Preventing Recurrent Vulvovaginal Candidiasis and Recurrent Bacterial Vaginosis, Journal of Gynecology and Obstetrics.
Vol. 6, No. 4,
2018, pp. 94-97.
Copyright © 2018 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/
) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Xie Xing. Obstetrics and Gynecology [M]. 8th Edition. Beijing; People's Medical Publishing House, 2013: 248-250.
Sobel JD. Vulvovaginal candidosis [J]. Lancet, 2007, 369(9577):1961-1971.
Achkar JM, Fries BC. Candida infections of the genitourinarytract [J]. Clin Microbiol Rev, 2010, 23(2): 253-273.
Ono F, Yasumoto S. Genital candidiasis [J]. Nippon Rinsho, 2009, 67(1): 157-161.
El Din SS. Reynolds MT, Ashbee HR. et al. An investigation in -to the pathogenesis of vulvovaginal candidosis [J]. Sex TransmInfect, 2001, 77(3): l 79-183.
Su Yuanyuan, Han Yanhua, Li Danyan. Female pelvic floor function and evaluation method of pelvic floor muscle function [J]. Chinese Journal of Practical Gynecology and Obstetrics, 2015, 31(4):310-313.
Zhang Jie, Wang Zhongmin, Ma Le, et al. Stress urinary incontinence caused by imbalance of levator ani muscle tension on both sides of postpartum [J]. Chinese Journal of Practical Gynecology and Obstetrics, 2015, 31(12): 1172-1173.
Ferreira C, Silva S, Faria-Oliveira F, et al. Candida albicansvirulence and drug- resistance requires the 0- acyltransferase Guplp [J]. BMC Microbiol, 2010, 10: 238-240.
Chong PP, Lee YL, Tan BC, et a1. Genetic relatedness of Can-dida strains isolated from women, IVith vaginal candidiasis in Malaysia [J]. J Med Microbiol, 2003, 52(Pt 8):657-666.
Lockhart SR, Rccd BD, Pierson CL, et al. Most frequent scenario for recurrent Candida vaginitis is strain maintenance with "substrain shuffling": demonstration by sequential DNA finger- printing with probes Ca3, C 1, and CARE2 [J]. J Clin Micro-biol, 1996, 34(4):767-777.
Li Ping. The risk of bacterial vaginitis on premature delivery and miscarriage [J]. Foreign Medical Intelligence, 1994, 15(18):98-99.
Hay-Smith EJ, Dumoulin C. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontience in women [J]. Cochrane Database Syst Rev, 2006, 25: CD005654.